Page last updated: 2024-09-03

5-bromo-2',3'-dideoxyuridine and clarithromycin

5-bromo-2',3'-dideoxyuridine has been researched along with clarithromycin in 1 studies

Compound Research Comparison

Studies
(5-bromo-2',3'-dideoxyuridine)
Trials
(5-bromo-2',3'-dideoxyuridine)
Recent Studies (post-2010)
(5-bromo-2',3'-dideoxyuridine)
Studies
(clarithromycin)
Trials
(clarithromycin)
Recent Studies (post-2010) (clarithromycin)
8017,1491,6062,504

Protein Interaction Comparison

ProteinTaxonomy5-bromo-2',3'-dideoxyuridine (IC50)clarithromycin (IC50)
ATP-dependent translocase ABCB1Homo sapiens (human)5.5
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)3.3113
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)3.0903

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agrawal, B; Johar, M; Kumar, R; Kunimoto, DY; Manning, T; Rai, D; Srivastav, NC1

Other Studies

1 other study(ies) available for 5-bromo-2',3'-dideoxyuridine and clarithromycin

ArticleYear
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
    Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19

    Topics: Adenosine; Alkynes; Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dideoxynucleosides; Drug Resistance, Bacterial; Guanosine; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Purine Nucleosides; Structure-Activity Relationship; Uridine

2007